ACM
Arlington Capital Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Hold |
1,506
| – | – | 0.24% | 66 |
|
|
2025
Q1 | $316K | Hold |
1,506
| – | – | 0.24% | 46 |
|
|
2024
Q4 | $268K | Hold |
1,506
| – | – | 0.19% | 67 |
|
|
2024
Q3 | $297K | Buy |
1,506
+202
| +15% | +$39.9K | 0.24% | 59 |
|
|
2024
Q2 | $224K | Sell |
1,304
-192
| -13% | -$32.9K | 0.19% | 67 |
|
|
2024
Q1 | $272K | Hold |
1,496
| – | – | 0.23% | 68 |
|
|
2023
Q4 | $232K | Sell |
1,496
-466
| -24% | -$72.2K | 0.21% | 79 |
|
|
2023
Q3 | $292K | Sell |
1,962
-85
| -4% | -$12.7K | 0.31% | 52 |
|
|
2023
Q2 | $276K | Hold |
2,047
| – | – | 0.24% | 69 |
|
|
2023
Q1 | $326K | Sell |
2,047
-130
| -6% | -$20.7K | 0.31% | 61 |
|
|
2022
Q4 | $352K | Buy |
2,177
+309
| +17% | +$49.9K | 0.39% | 52 |
|
|
2022
Q3 | $251K | Buy |
+1,868
| New | +$251K | 0.62% | 13 |
|
|
2022
Q2 | – | Sell |
-2,335
| Closed | -$379K | – | 3 |
|
|
2022
Q1 | $379K | Hold |
2,335
| – | – | 1.54% | 24 |
|
|
2021
Q4 | $316K | Buy |
+2,335
| New | +$316K | 0.57% | 54 |
|
|
2021
Q3 | – | Sell |
-2,457
| Closed | -$277K | – | 53 |
|
|
2021
Q2 | $277K | Buy |
2,457
+122
| +5% | +$13.8K | 0.56% | 45 |
|
|
2021
Q1 | $253K | Sell |
2,335
-788
| -25% | -$85.4K | 0.46% | 44 |
|
|
2020
Q4 | $335K | Buy |
+3,123
| New | +$335K | 0.46% | 46 |
|